Hailong Tang
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Multi-center validation of a machine learning model for early detection of monoclonal immunoglobulin-related disorders using routine laboratory data.
Journal: Frontiers in immunology
Published: April 15, 2026
Zalcitabine induces ferroptosis in multiple myeloma through the TFAM-cGAS-STING-SLC7A11 axis.
Journal: Journal of translational medicine
Published: September 28, 2025
Establishment and validation of a clinical threshold criteria for choosing PET imaging tracers for indolent non-Hodgkin's lymphoma.
Journal: EJNMMI research
Published: September 01, 2025
Development and validation of a novel frailty model for the patients with newly diagnosed multiple myeloma.
Journal: European journal of medical research
Published: January 23, 2025
A new chemotherapy-free regimen of olverembatinib in combination with venetoclax and dexamethasone for newly diagnosed Ph+ acute lymphoblastic leukemia: Preliminary outcomes of a prospective study.
Journal: American journal of hematology
Published: December 01, 2023
Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens.
Journal: Frontiers in oncology
Published: May 07, 2022
Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities.
Journal: Frontiers in oncology
Published: October 30, 2021
Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia.
Journal: BMC medical genomics
Published: October 27, 2021
Treatment options for older unfit patients with acute myeloid leukemia.
Journal: Future oncology (London, England)
Published: February 01, 2021
Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.
Journal: Cell transplantation
Published: November 26, 2020
CDK5 inhibition in vitro and in vivo induces cell death in myeloma and overcomes the obstacle of bortezomib resistance.
Journal: International journal of molecular medicine
Published: October 06, 2019
Momelotinib for the treatment of myelofibrosis.
Journal: Expert opinion on pharmacotherapy
Published: August 28, 2019
Last Updated: 09/26/2026